| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.48 | 0.01 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |